Weidong Wei

1.9k total citations
38 papers, 1.5k citations indexed

About

Weidong Wei is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Weidong Wei has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Weidong Wei's work include MicroRNA in disease regulation (5 papers), HER2/EGFR in Cancer Research (4 papers) and Lung Cancer Research Studies (4 papers). Weidong Wei is often cited by papers focused on MicroRNA in disease regulation (5 papers), HER2/EGFR in Cancer Research (4 papers) and Lung Cancer Research Studies (4 papers). Weidong Wei collaborates with scholars based in China, United States and Switzerland. Weidong Wei's co-authors include Xiaoming Xie, Hailin Tang, Danian Dai, Yanan Kong, Xinhua Xie, Lu Yang, Xiaojia Huang, Bo Chen, Bo Chen and Mingang Ying and has published in prestigious journals such as PLoS ONE, Journal of Materials Chemistry A and Cancer Letters.

In The Last Decade

Weidong Wei

38 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weidong Wei China 21 759 666 366 169 124 38 1.5k
Mingzhen Li China 19 873 1.2× 490 0.7× 106 0.3× 92 0.5× 140 1.1× 86 1.6k
Jie Fu China 21 741 1.0× 205 0.3× 371 1.0× 256 1.5× 107 0.9× 99 1.5k
Qin Jin China 25 569 0.7× 187 0.3× 224 0.6× 127 0.8× 198 1.6× 81 1.5k
Zihang Zeng China 19 382 0.5× 204 0.3× 147 0.4× 249 1.5× 46 0.4× 74 1.0k
Bernd Schmidt Germany 26 732 1.0× 518 0.8× 251 0.7× 656 3.9× 144 1.2× 76 1.9k
Ruoxin Zhang China 18 345 0.5× 191 0.3× 190 0.5× 127 0.8× 99 0.8× 62 1.1k
Xuefei Zhang China 18 523 0.7× 267 0.4× 141 0.4× 335 2.0× 105 0.8× 77 1.4k
Sheng‐Ming Wu Taiwan 25 794 1.0× 397 0.6× 381 1.0× 300 1.8× 61 0.5× 90 1.8k
Chia‐Cheng Yu Taiwan 20 446 0.6× 264 0.4× 199 0.5× 451 2.7× 125 1.0× 79 1.2k
Gottfried Schmer United States 19 417 0.5× 225 0.3× 60 0.2× 437 2.6× 213 1.7× 62 1.9k

Countries citing papers authored by Weidong Wei

Since Specialization
Citations

This map shows the geographic impact of Weidong Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weidong Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weidong Wei more than expected).

Fields of papers citing papers by Weidong Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weidong Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weidong Wei. The network helps show where Weidong Wei may publish in the future.

Co-authorship network of co-authors of Weidong Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Weidong Wei. A scholar is included among the top collaborators of Weidong Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weidong Wei. Weidong Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Weidong, Qing Zhang, Shaohua Qu, et al.. (2023). A retrospective cohort study of tamoxifen versus surgical treatment for ER-positive gynecomastia. BMC Endocrine Disorders. 23(1). 62–62. 1 indexed citations
2.
Xie, Jindong, Yutian Zou, Feng Ye, et al.. (2022). A Novel Platelet-Related Gene Signature for Predicting the Prognosis of Triple-Negative Breast Cancer. Frontiers in Cell and Developmental Biology. 9. 795600–795600. 28 indexed citations
3.
Li, Shuman, Qing‐Mei He, Weidong Wei, et al.. (2019). <p>The Prognostic Significance Of JMJD3 In Primary Sarcomatoid Carcinoma Of The Lung, A Rare Subtype Of Lung Cancer</p>. OncoTargets and Therapy. Volume 12. 9385–9393. 9 indexed citations
4.
Li, Xuan, Danian Dai, Qing Chen, et al.. (2018). The value of neutrophil-to-lymphocyte ratio for response and prognostic effect of neoadjuvant chemotherapy in solid tumors: A systematic review and meta-analysis. Journal of Cancer. 9(5). 861–871. 49 indexed citations
5.
Chen, Bo, Weidong Wei, Xiaojia Huang, et al.. (2018). circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression. Theranostics. 8(14). 4003–4015. 212 indexed citations
6.
Kong, Yanan, Ning Lyu, Jiali Wu, et al.. (2018). Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer. Journal of Cancer. 9(20). 3728–3735. 36 indexed citations
7.
Li, Xuan, Danian Dai, Qing Chen, Hailin Tang, & Weidong Wei. (2017). Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: a systematic review and meta-analysis. World Journal of Surgical Oncology. 15(1). 210–210. 18 indexed citations
8.
Chen, Bo, Danian Dai, Hailin Tang, et al.. (2016). Pre-treatment serum alkaline phosphatase and lactate dehydrogenase as prognostic factors in triple negative breast cancer. Journal of Cancer. 7(15). 2309–2316. 38 indexed citations
9.
Dai, Danian, Bo Chen, Hailin Tang, et al.. (2016). Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients. PLoS ONE. 11(8). e0161902–e0161902. 25 indexed citations
10.
Lin, Xiaoti, Weiyu Chen, Fengqin Wei, et al.. (2015). Night-shift work increases morbidity of breast cancer and all-cause mortality: a meta-analysis of 16 prospective cohort studies. Sleep Medicine. 16(11). 1381–1387. 118 indexed citations
11.
Lin, Xiaoti, Jingjing Li, Weiyu Chen, et al.. (2015). Diabetes and risk of anastomotic leakage after gastrointestinal surgery. Journal of Surgical Research. 196(2). 294–301. 35 indexed citations
12.
Lv, Ning, Ni He, Chuanmiao Xie, et al.. (2014). Effect of vascular haemoglobin concentrations on ultrasound-guided diffuse optical tomography in differentiating benign from malignant breast lesions. European Radiology. 24(11). 2848–2856. 6 indexed citations
13.
Xie, Xinhua, Hailin Tang, Peng Liu, et al.. (2014). Development of PEA-15 using a potent non-viral vector for therapeutic application in breast cancer. Cancer Letters. 356(2). 374–381. 9 indexed citations
14.
Guo, Jiaoli, Xinhua Xie, Laisheng Li, et al.. (2013). Synergistic effects of curcumin with emodin against the proliferation and invasion of breast cancer cells through upregulation of miR-34a. Molecular and Cellular Biochemistry. 382(1-2). 103–111. 94 indexed citations
15.
Lv, Ning, Suxia Lin, Zeming Xie, et al.. (2012). Absence of evidence for epidermal growth factor receptor and human homolog of the Kirsten rat sarcoma-2 virus oncogene mutations in breast cancer. Cancer Epidemiology. 36(4). 341–346. 4 indexed citations
16.
Wu, Minqing, Weidong Wei, Xiangsheng Xiao, et al.. (2012). Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer. Medical Oncology. 29(5). 3240–3249. 72 indexed citations
17.
Li, Laisheng, Xinhua Xie, Min Liu, et al.. (2012). Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion. Molecular Therapy. 20(12). 2326–2334. 88 indexed citations
18.
Lv, Ning, Xiaoming Xie, Suxia Lin, et al.. (2011). Epidermal growth factor receptor in breast carcinoma: association between gene copy number and mutations. Diagnostic Pathology. 6(1). 118–118. 30 indexed citations
19.
Chen, Likun, You‐Jian He, He Huang, Hai Liao, & Weidong Wei. (2008). Selective COX-2 inhibitor celecoxib combined with EGFR-TKI ZD1839 on non-small cell lung cancer cell lines: in vitro toxicity and mechanism study. Medical Oncology. 25(2). 161–171. 23 indexed citations
20.
Yan, Wensheng, Lanying Song, Weidong Wei, et al.. (2005). Chromosomal Abnormalities Associated with Neck Nodal Metastasis in Nasopharyngeal Carcinoma. Tumor Biology. 26(6). 306–312. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingzhen Li Breakdown of academic impact, for papers by Jie Fu Breakdown of academic impact, for papers by Qin Jin Breakdown of academic impact, for papers by Zihang Zeng Breakdown of academic impact, for papers by Bernd Schmidt Breakdown of academic impact, for papers by Ruoxin Zhang Breakdown of academic impact, for papers by Xuefei Zhang Breakdown of academic impact, for papers by Sheng‐Ming Wu Breakdown of academic impact, for papers by Chia‐Cheng Yu Breakdown of academic impact, for papers by Gottfried Schmer
Rankless by CCL
2026